HOME >> BIOLOGY >> NEWS
New findings point to new target to block angiogenesis

NASHVILLE, Tenn. - Cutting off supply lines is a sure way to strangle and defeat an enemy army. The strategy is being applied to the war against tumors, which require supply lines-new blood vessels-to support their growth and metastasis. Scientists at the Vanderbilt-Ingram Cancer Center have identified an unexpected participant in the process of blood vessel development. Reported in the Sept. 15 issue of the journal Cancer Research, their findings point to a new target for drugs that inhibit this process, angiogenesis.

Previous work from multiple laboratories had suggested that the enzyme cyclooxygenase-2 (COX-2) contributes to the blood vessel development associated with tumors. To determine which of many COX-2 products participate in angiogenesis, Dr. Thomas Daniel, director of Vanderbilt's Vascular Biology Center, took advantage of a cultured endothelial cell system developed in his laboratory. The cultured cells migrate in response to angiogenic signals, just as they would in order to form new blood vessels in vivo.

Collaborator Dr. Jason D. Morrow, a professor of Medicine and Pharmacology, used a technique called mass spectrometry to establish that the activated endothelial cells generate the COX-2 products PGE2, thromboxane A2, and PGF2alpha. COX-2 inhibitors developed by biochemist Lawrence J. Marnett, Ph.D., associate director of research programs at the Vanderbilt-Ingram Cancer Center, prevented the formation of all of these products and blocked the cell migration response. Of the three products, only thromboxane A2 turned out to have a functional role in endothelial cell migration.

"Adding back thromboxane A2 under COX-2-inhibited conditions reconstituted cell migration," Daniel said.

Drugs that block the thromboxane A2 receptor also halted endothelial cell migration.

Using a model of angiogenesis in the mouse cornea, Daniel showed that the findings were not limited to cultured cells. "All of our in vitro observations implicating throm
'"/>

Contact: Cynthia Manley
cynthia.manley@mcmail.vanderbilt.edu
615-322-4747
Vanderbilt University Medical Center
15-Sep-1999


Page: 1 2

Related biology news :

1. International study findings link acne-like rash to effectiveness of new targeted cancer treatment
2. Virginia Tech researchers to release findings on Smith River Project
3. New HIV findings
4. Stanford researchers findings may shed light on common, deadly birth defect
5. Briggs takes to the molecular level Darwins findings on plants sensing the direction of light
6. Latest findings on PCBs to be subject of June workshop at Illinois
7. Chlamydia in men now also linked to infertility new findings
8. New MS research shows remarkable findings
9. Scientists findings may lead to better understanding of how that sleep develops, matures
10. New findings are a window into the late stages of Lou Gehrigs disease
11. New findings bring mixed blessings to those looking to combat jet lag

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/13/2017)... , April 13, 2017 UBM,s Advanced Design ... will feature emerging and evolving technology through its ... Summits will run alongside the expo portion of the ... panels and demonstrations focused on trending topics within 3D ... design and manufacturing event will take place June 13-15, 2017 ...
(Date:4/11/2017)... , April 11, 2017 NXT-ID, ... security technology company, announces the appointment of independent Directors Mr. ... to its Board of Directors, furthering the company,s corporate ... ... NXT-ID, we look forward to their guidance and benefiting from ...
(Date:4/4/2017)... NEW YORK , April 4, 2017   ... solutions, today announced that the United States Patent and ... The patent broadly covers the linking of an iris ... the same transaction) and represents the company,s 45 th ... our latest patent is very timely given the multi-modal ...
Breaking Biology News(10 mins):
(Date:10/9/2017)... ... October 09, 2017 , ... The Giving Tree ... products targeting the needs of consumers who are incorporating medical marijuana into their ... Phoenix, Arizona. , As operators of two successful Valley dispensaries, The Giving Tree’s ...
(Date:10/7/2017)... Phoenix, Arizona (PRWEB) , ... ... ... than 15 years’ experience providing advanced instruments and applications consulting for microscopy ... the in-house expertise in application consulting, Nanoscience Analytical offers a broad range ...
(Date:10/7/2017)... , Oct. 6, 2017  The 2017 Nobel ... three scientists, Jacques Dubochet, Joachim Frank ... in cryo-electron microscopy (cryo-EM) have helped ... the structural biology community. The winners worked with ... now routinely produce highly resolved, three-dimensional images of ...
(Date:10/6/2017)... ... 06, 2017 , ... On Tuesday, October 24th, ABC² (Accelerate ... first-ever adaptive clinical trial for glioblastoma (GBM). The featured speaker will be Dr. ... open to the public, but registration is required. , WHAT: ABC² Brain ...
Breaking Biology Technology:
Cached News: